Xeris Biopharma Holdings, Inc. Common Stock XERS

$10.07 -0.59% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-09-29 View →
8-K 8-K 2026-09-09 View →
4 FORM 4 2026-09-01 View →
4 FORM 4 2026-09-01 View →
4 FORM 4 2026-09-01 View →
4 FORM 4 2026-08-21 View →
4 FORM 4 2026-08-21 View →
4 FORM 4 2026-08-12 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
4 FORM 4 2026-08-04 View →
4 FORM 4 2026-08-04 View →
8-K 8-K 2026-07-17 View →
4 FORM 4 2026-07-07 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-02 View →
8-K 8-K 2026-06-30 View →
8-K 8-K 2026-06-11 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
8-K 8-K 2026-06-05 View →
4 FORM 4 2026-06-02 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-05-07 View →
4 FORM 4 2026-05-01 View →
DEF 14A DEF 14A 2026-04-23 View →
8-K 8-K 2026-04-21 View →
4 FORM 4 2026-04-03 View →
4 FORM 4 2026-04-01 View →
4 FORM 4 2026-03-16 View →
4 FORM 4 2026-03-05 View →
4 FORM 4 2026-03-04 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$10.07
Market Cap
$1.85 billion
52-Week Range
$5.25 – $11.33
Average Volume
2.73 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.